Burkina Faso vs Zambia: Population requiring preventive chemotherapy for schistosomiasis
Burkina Faso
4.46 million
in 2024
Zambia
4.79 million
in 2024
Burkina Faso rank
19th
Zambia rank
17th
Population requiring preventive chemotherapy for schistosomiasis over time
- Burkina Faso
- Zambia
How they compare
Zambia currently reports 4.79 million against 4.46 million in Burkina Faso, a difference of 329,780.
That makes Zambia's figure about 1.1 times Burkina Faso's.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Zambia ahead.
Burkina Faso ranks 19th and Zambia ranks 17th of 52 countries.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.88 million | 4.65 million | 770,767 | Zambia |
| 2020s | 3.48 million | 4.50 million | 1.02 million | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Burkina Faso or Zambia?
- Zambia, at 4.79 million against 4.46 million in Burkina Faso as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Burkina Faso and Zambia?
- 329,780, with Zambia ahead.
- How many years of comparable data are there for Burkina Faso and Zambia?
- 15 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Zambia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Burkina Faso ranks 19th and Zambia ranks 17th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.